Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan;15(1):116-9.
doi: 10.1177/1352458508096868. Epub 2008 Sep 19.

CNS Demyelination and Quadrivalent HPV Vaccination

Affiliations

CNS Demyelination and Quadrivalent HPV Vaccination

I Sutton et al. Mult Scler. .

Abstract

Vaccination is generally considered safe in patients with multiple sclerosis (MS). We report five patients who presented with multifocal or atypical demyelinating syndromes within 21 days of immunization with the quadrivalent human papilloma virus (HPV) vaccine, Gardasil. Although the target population for vaccination, young females, has an inherently high risk for MS, the temporal association with demyelinating events in these cases may be explained by the potent immuno-stimulatory properties of HPV virus-like particles which comprise the vaccine. A prospective case-control study of patients with MS or clinically isolated demyelinating syndromes receiving the Gardasil vaccine may provide relevant safety data in this population.

Similar articles

See all similar articles

Cited by 26 articles

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources

Feedback